Send me a link:

*Text messaging rates may apply.

 Dow Down 0.19% Nasdaq Up 0.45%

Keryx Biopharmaceuticals Inc. (KERX)

-NasdaqCM
15.35 0.08(0.52%) Jul 30, 4:00PM EDT
|After Hours : 15.30 Down 0.05 (0.33%) Jul 30, 7:23PM EDT
Prev Close:15.27
Open:15.45
Bid:15.35 x 200
Ask:15.70 x 700
1y Target Est:24.00
Beta:4.23
Next Earnings Date:N/A
Day's Range:15.27 - 15.80
52wk Range:8.29 - 17.46
Volume:1,090,406
Avg Vol (3m):1,622,130
Market Cap:1.40B
P/E (ttm):N/A
EPS (ttm):-0.70
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for KERX

Comparison

Symbol% ChgMkt Cap
KERXUp 0.52%1.40B
BAX41.29B
SHPG49.11B

Key Statistics

Forward P/E (1 yr):76.75
P/S (ttm):139.65
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.80
Quarterly EPS Est (Jun-14) :-0.25
Mean Recommendation*:1.6
PEG Ratio (5 yr expected):-0.64

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Keryx Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of pharmaceutical products for the treatment of renal disease in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback